Skip to main content
Clinical Trials/NCT04781452
NCT04781452RecruitingNot Applicable

Evaluating the Treatment in the the Center for Disabled People in Aachen (MZEB Aachen) - a Registry on Patients With Severe Disabilities

RWTH Aachen University1 site in 1 country2,000 target enrollmentStarted: July 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
2,000
Locations
1
Primary Endpoint
change in number of therapy sessions

Study Overview

Brief Summary

Evaluation of patient characteristics, involved physicians and therapists as well as therapies in a German University Center for the Treatment of patients with intellectual disabilities and severe multiple disability (MZEB Aachen)

Detailed Description

In the MZEB Aachen, since 11/2018 patients with intellectual disabilities and/or severe multiple disabilities are diagnosed, treated and accompanied for many years in a multidisciplinary setting with physicians, nurses, physiotherapists, ergo therapists, speech therapists and Support by social workers. MZEBs are considered to have a pilot function in the health care system, cooperating with therapists and physicians in the surroundings. This concept is established as a new concept in Germany in order to optimise health care for patients with disabilities. Thus we want to investigate patient characteristics, diagnoses, involved physicians and therapists as well as proposed therapies and disease progress in this center.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • intellectual disability and/or severe multiple disability (disability degree GdB at least 70 and at least one noticeable sign
  • willing to participate

Exclusion Criteria

  • housed in an Institution and/or prison

Outcomes

Primary Outcomes

change in number of therapy sessions

Time Frame: baseline and after one year treatment

change in the number of therapy sessions per month

Change in diagnoses

Time Frame: baseline and after one year treatment

Change in percentage of definite diagnoses

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andrea Maier

Principal Investigator

RWTH Aachen University

Study Sites (1)

Loading locations...

Similar Trials

Evaluating the Treatment in the MZEB Aachen | Clinical Trial